Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Senator Udall Favors Lower Drug Prices, But Not Through Importation

Executive Summary

Mark Udall, D-Colo., moves to the Senate with a health care record in the House that includes a "no" vote in 2003 on the Medicare Part D prescription benefit program

You may also be interested in...

Changing Part D Donut Hole “A Very Expensive Fix,” Daschle Notes

Changing the "donut hole" in Medicare Part D drug reimbursement and allowing the government to negotiate prices for seniors' medicines will be on the table as the Obama Administration develops its health care proposals

Sens. Baucus, Grassley Head Down Diverging Paths On Drug Price Negotiation As House Clears Pricing Measure

Baucus now favors repealing the noninterference clause but proceeding “cautiously.” Spotlight shifts to the Senate after the House clears HR 4.

Rx Reimportation Passes House; CBO Score May Keep It Out Of Medicare Rx

The Congressional Budget Office's determination that prescription drug reimportation would not provide any cost savings could help House/Senate Medicare conferees distance themselves from the House's positive vote on reimportation





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts